How would you manage subclinical ILD associated with MDA-5 Dermatomyositis?

Topics: Rheumatology • Myositis • Dermatomyositis • Pulmonology • Dermatology • MDA5 • ILD

Any indications for triple therapy in the patients with subclinical ILD associated with MDA-5 dermatomyositis?

Answer from: at Academic Institution

Subclinical ILD in anti-MDA5 is like a time bomb waiting to explode. Would do aggressive monitoring for ILD symptoms/tests and give at least 1st line immunosuppression with CellCept or tacrolimus.

Related Questions